167 related articles for article (PubMed ID: 1340154)
1. Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides.
Neckers L; Rosolen A; Fahmy B; Whitesell L
Ann N Y Acad Sci; 1992 Oct; 660():37-44. PubMed ID: 1340154
[No Abstract] [Full Text] [Related]
2. Antisense inhibition of gene expression: a tool for studying the role of NMYC in the growth and differentiation of neuroectoderm-derived cells.
Neckers LM; Rosolen A; Whitesell L
J Immunother (1991); 1992 Oct; 12(3):162-6. PubMed ID: 1332744
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: a question of mechanism.
Stein CA
J Natl Cancer Inst; 1996 Apr; 88(7):391-3. PubMed ID: 8618230
[No Abstract] [Full Text] [Related]
4. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligodeoxynucleotides as probes of T-lymphocyte gene function.
Green DR; Zheng H; Shi Y
Ann N Y Acad Sci; 1992 Oct; 660():193-203. PubMed ID: 1340120
[TBL] [Abstract][Full Text] [Related]
6. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
7. Antisense inhibition of oncogene expression.
Neckers L; Whitesell L; Rosolen A; Geselowitz DA
Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
[TBL] [Abstract][Full Text] [Related]
8. Antisense of oligonucleotides and the inhibition of oncogene expression.
Prins J; de Vries EG; Mulder NH
Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
[TBL] [Abstract][Full Text] [Related]
9. The use of antisense approaches to study development.
Erickson RP
Dev Genet; 1993; 14(4):251-7. PubMed ID: 8222342
[No Abstract] [Full Text] [Related]
10. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
Calabretta B
Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
[No Abstract] [Full Text] [Related]
11. Protooncogenes in the regulation of normal hematopoiesis. An antisense approach.
Calabretta B; Skorski T; Szczylik C; Caracciolo D; Valtieri M; Venturelli D
Ann N Y Acad Sci; 1992 Oct; 660():117-23. PubMed ID: 1285069
[No Abstract] [Full Text] [Related]
12. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
Abdel-Mageed A; Agrawal KC
Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
[TBL] [Abstract][Full Text] [Related]
13. Gene regulation by antisense RNA and DNA.
Case CC; Dhundale AR
Antisense Res Dev; 1991; 1(2):207-17. PubMed ID: 1841663
[No Abstract] [Full Text] [Related]
14. In vivo studies with antisense oligonucleotides.
Akhtar S; Agrawal S
Trends Pharmacol Sci; 1997 Jan; 18(1):12-8. PubMed ID: 9114724
[No Abstract] [Full Text] [Related]
15. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
Nesterova M; Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
17. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
Hélène C
Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
19. Antisense inhibition of CHP100 C-myc expression results in reduced in vitro growth kinetics and loss of in vivo tumorigenesis.
Rosolen A; Toretsky J; Neckers L
Prog Clin Biol Res; 1994; 385():95-101. PubMed ID: 7972241
[No Abstract] [Full Text] [Related]
20. Antisense strategies: functions and applications in immunology.
Varga LV; Tóth S; Novák I; Falus A
Immunol Lett; 1999 Aug; 69(2):217-24. PubMed ID: 10482355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
